Tofacitinib in Recurrent GBM Patients
NCT05326464
·
clinicaltrials.gov ↗
PHASE3
Phase
ACTIVE_NOT_RECRUITING
Status
17
Enrollment
OTHER
Sponsor class
Conditions
Glioblastoma
Interventions
DRUG:
Tofacitinib 10mg
Sponsor
University of Texas Southwestern Medical Center
Collaborators
[object Object]